当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2011年第21期 > 正文
编号:12136285
室壁局部功能测定对靶剂量培哚普利联合美托洛尔治疗急性心肌梗死合并心功能不全疗效评价(3)
http://www.100md.com 2011年7月25日 倪 华 刘澄英 沙江明 邵 荣 申 怡 高春恒 王东升
第1页

    参见附件(3939KB,4页)。

     [参考文献]

    [1]王雪,张梅,张运,等.实时三维超声对心肌梗死患者左心室局部心肌容量和收缩功能的分析[J].中华超声影像学杂志,2006,15(5):325-328.

    [2]Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology [J]. Eur Heart J,2005,26:1115-1140.

    [3]Cleland JG, Tendera M, Adamus J, et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study [J]. Eur Heart J,2006,27:2338-2345.

    [4]McAlister FA, Stewart S, Ferrua S, et al. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials[J]. J Am Coll Cardiol,2004,44:810-819.

    [5]Brugts JJ, Ninomiya T, Boersma E, et al. The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials [J]. Eur Heart J,2009,30:1385-1394.

    [6]Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology ......

您现在查看是摘要介绍页,详见PDF附件(3939KB,4页)